|
Real-time Estimate
Cboe BZX
19:40:15 02/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 15.86 USD | +0.28% |
|
-0.19% | +99.12% |
| 10-27 | Alert from law firm tagged to Personalis withdrawn | RE |
| 10-21 | Personalis, Inc. Announces NeXT Personal Ultrasensitive Circulating Tumor DNA Test Presentations at ESMO Congress 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.69B | - | - | - | ||
| 115B | |||||
| 98.85B | |||||
| 59.72B | - | ||||
| 30.06B | |||||
| 29.34B |
- Stock Market
- Stocks
- PSNL Stock
- Charts Personalis, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
